Auris Medical Announces Acquisition of Orphan Drug Designation and Secures Rights to In-License Additional Patents Related to Betahistine

World News: . []

Zug Switzerland December 6 2018 - Auris Medical Holding AG NASDAQ EARS a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health supportive care today announced a strat...

More news and information about Auris Medical AG

Published By:

Globe Newswire: 12:31 GMT Thursday 6th December 2018

Published: .

Search for other references to "auris" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us